Arbutus Biopharma Corp
ABUS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001447028
No open-market purchases or sales by Arbutus Biopharma Corp insiders were filed in the last 90 days; 176 institutions reported holding it in 13F filings for Q2 2026, worth $674.9M in total; no superinvestor holds it.
Q1 2024 vs. Q4 2023
How the institutions holding Arbutus Biopharma Corp changed between Q4 2023 and Q1 2024.
All holders in Q1 2024All holders in Q4 2023
| Measure | Q4 2023 | Q1 2024 | Change |
|---|---|---|---|
| Holders | 112 | 119 | +7 |
| Shares | 79.0M | 83.4M | +4.46M (+5.6%) |
| Value | $197.4M | $215.2M | +$17.8M (+9.0%) |
New holders (20)
Institutions that held Arbutus Biopharma Corp at the end of Q1 2024 but not at the end of Q4 2023.
Sold out (13)
Institutions that held Arbutus Biopharma Corp at the end of Q4 2023 and filed for Q1 2024 without it.
| Institution | Shares, Q4 2023 | Value, Q4 2023 |
|---|---|---|
| Assenagon Asset Management S.A. | 817,574 | $2.04M |
| Tejara Capital Ltd | 180,077 | $450.2K |
| Point72 Asset Management, L.P. | 105,000 | $262.5K |
| Caption Management, LLC | 42,736 | $106.8K |
| State Board of Administration of Florida Retirement System | 35,820 | $89.5K |
| Virtu Financial LLC | 17,923 | $45.0K |
| Arete Wealth Advisors, LLC | 15,000 | $37.5K |
| Brown, Lisle/Cummings, Inc. | 7,500 | $18.8K |
| Cubist Systematic Strategies, LLC | 7,192 | $18.0K |
| DAGCO, Inc. | 6,300 | $15.8K |
| Cutler Group LP | 4,500 | $11.0K |
| Qube Research & Technologies Ltd | 1,685 | $4.21K |
| Blue Bell Private Wealth Management, LLC | 500 | $1.25K |